(Q34560666)

3 August 2017

Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. (English)

1 reference

3 August 2017

Yasuhito Taniguchi

1

1 reference

3 August 2017

Hiroko Tonai-Kachi

series ordinal

2

1 reference

3 August 2017

Katsuhiro Shinjo

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

17 August 2006

1 reference

3 August 2017

1 reference

3 August 2017

580

1 reference

3 August 2017

5003-5008

1 reference

3 August 2017

21

1 reference

Target validation of G-protein coupled receptors

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Discovery of three novel G-protein-coupled receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Cyclic nucleotide phosphodiesterases: relating structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

PDE4 cAMP-specific phosphodiesterases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Techniques: promiscuous Galpha proteins in basic research and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Lack of the nitric oxide-cyclic GMP-potassium channel pathway for the antinociceptive effect of intrathecal zaprinast in a rat formalin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Phosphodiesterase 5 inhibitors: current status and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.08.015

10.1016/J.FEBSLET.2006.08.015

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference